Your Health, We Care
Fezolinetant is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.
from FDA，2024.08
LuciusVersionofFezolinetant:DosageandAdministration,Indications,PrecautionsIndicationsFezolinetant i···【more】
Recommended：542025-10-12
Lucius Version of Fezolinetant: Dosage and Administration, Indications, PrecautionsIndicationsFezoli···【more】
Recommended：562025-09-12
Fezolinetant is indicated for the treatment of vasomotor symptoms due to menopause.【more】
Article source：Lucius LaosRelease date：2026-01-05Recommended：18
LuciusVersionofFezolinetant:DosageandAdministration,Indications,PrecautionsIndicationsFezolinetant is the first non-hormonal therapy for the treatment of moderate to severe vasomot···【more】
Article source：Lucius LaosRelease date：2025-12-10Recommended：54
Lucius Version of Fezolinetant: Dosage and Administration, Indications, PrecautionsIndicationsFezolinetant is the first non-hormonal therapy for the treatment of moderate to severe···【more】
Article source：Lucius LaosRelease date：2025-12-09Recommended：56
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
